Does DACLIZUMAB Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with DACLIZUMAB. This represents 0.2% of all adverse event reports for DACLIZUMAB.
5
Reports of Neoplasm malignant with DACLIZUMAB
0.2%
of all DACLIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From DACLIZUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant dysfunction (421)
Transplant rejection (385)
Acne (382)
Ovarian cyst (374)
Multiple sclerosis relapse (313)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DACLIZUMAB Alternatives Have Lower Neoplasm malignant Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN